We are live on
!
Find out more
Moleculin Biotech
MBRX
MBRX
24 hedge funds and large institutions have $413K invested in Moleculin Biotech in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.06% less ownership
Funds ownership: 0.12% → 0.06% (-0.06%)
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$113K | |
| 2 | +$97.6K | |
| 3 | +$62.2K | |
| 4 |
IC
IEQ Capital
Foster City,
California
|
+$19.7K |
| 5 |
WDG
Wealth Dimensions Group
Cincinnati,
Ohio
|
+$10.8K |
Top Sellers
| 1 | -$25.7K | |
| 2 | -$22.4K | |
| 3 | -$18K | |
| 4 |
VCP
Verus Capital Partners
Scottsdale,
Arizona
|
-$13K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.17K |